| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |


* Department of Chemistry,
Biophysics Research Division, and
Macromolecular Science and Engineering, University of Michigan, Ann Arbor, Michigan 48109-1055
Correspondence: Address reprint requests to A. Ramamoorthy, Tel.: 734-647-6572; Fax: 734-764-8776; E-mail: ramamoor{at}umich.edu.
| ABSTRACT |
|---|
|
|
|---|
-helical peptide designed by Genaera Corporation as a synthetic analog to peptides from the magainin family. 31P-NMR of mechanically aligned samples and differential scanning calorimetry (DSC) were used to study peptide-containing lipid bilayers. DSC showed that MSI-78 increased the fluid lamellar to inverted hexagonal phase transition temperature of 1,2-dipalmitoleoyl-phosphatidylethanolamine indicating the peptide induces positive curvature strain in lipid bilayers. 31P-NMR of lipid bilayers composed of MSI-78 and 1-palmitoyl-2-oleoyl-phosphatidylethanolamine demonstrated that the peptide inhibited the fluid lamellar to inverted hexagonal phase transition of 1-palmitoyl-2-oleoyl-phosphatidylethanolamine, supporting the DSC results, and the peptide did not induce the formation of nonlamellar phases, even at very high peptide concentrations (15 mol %). 31P-NMR of samples containing 1-palmitoyl-2-oleoyl-phosphatidylcholine and MSI-78 revealed that MSI-78 induces significant changes in the bilayer structure, particularly at high peptide concentrations. At lower concentrations (15%), the peptide altered the morphology of the bilayer in a way consistent with the formation of a toroidal pore. Higher concentrations of peptide (1015%) led to the formation of a mixture of normal hexagonal phase and lamellar phase lipids. This work shows that MSI-78 induces significant changes in lipid bilayers via positive curvature strain and presents a model consistent with both the observed spectral changes and previously published work. | INTRODUCTION |
|---|
|
|
|---|
MSI-78 is active against numerous bacterial strains, including strains that are resistant to conventional antibiotics (Maloy and Kari, 1995
), but no details are currently known about the peptide's mechanism. MSI-78 is an analog of the naturally occurring antimicrobial peptides that comprise the magainin family, which was initially isolated from the frog Xenopus laevis (Zasloff, 1987
). Magainin2 is thought to permeabilize cell membranes by forming toroidal-pores (Matsuzaki et al., 1998
). Since MSI-78 was designed to be
-helical and amphipathic to mimic magainins (Maloy and Kari, 1995
), we studied the peptide in lipid bilayers using 31P-NMR and differential scanning calorimetry (DSC) to determine if MSI-78 operates by a similar mechanism. 31P-NMR has been used to characterize lipids and their perturbation in many instances, including studies of peptide-induced changes in lipid phases (Gasset et al., 1988
; Killian and de Kruijff, 1985
; Keller et al., 1996
; Fenske and Jarrell, 1991
; Liu et al., 2001
). However, many of these studies used multilamellar dispersions for their 31P-NMR experiments, which complicate the analysis because of the broad, overlapping powder patterns resulting from mixtures of lipid phases. Mechanical alignment of the lipid bilayers circumvents this difficulty; it also increases spectral resolution and enhances the signal-to-noise ratio of the spectrum without any loss of information. Combining 31P-NMR with DSC allows for a more complete understanding of peptide-induced curvature strain in the membrane since DSC is often used to characterize spontaneous membrane curvature. In this study, we report data consistent with MSI-78 operating via a toroidal pore mechanism similar to magainin2.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Sample preparation
All mechanically aligned lipid samples used for NMR experiments were prepared using a naphthalene procedure published elsewhere (Hallock et al., 2002
). Briefly, the membrane components were dissolved in an excess of 2:1 CHCl3:CH3OH (4 mg of lipids and an appropriate amount of peptide to produce the desired mole percentage). The lipid-peptide solution was dried under a stream of N2 gas and redissolved in 2:1 CHCl3:CH3OH containing a 1:1 molar ratio of naphthalene to lipid-peptide. The solution was then dried on two thin glass plates (11 mm x 22 mm x 50 µm or 11 mm x 11 mm x 50 µm, Paul Marienfeld GmbH & Co., Bad Mergentheim, Germany). To remove the naphthalene and any residual organic solvent, the samples were vacuum dried for at least 6 h. After drying, the samples were indirectly hydrated in a sealed container with 93% relative humidity using a saturated NH4H2PO4 solution (Washburn et al., 1926
), for 12 days at 37°C, after which
2 µL of H2O was sprayed on the surface of the lipid-peptide film on the glass plates. The plates were stacked, wrapped with parafilm, sealed in plastic (Plastic Bagmart, Marietta, GA), and then equilibrated at 4°C for 12 days.
Solid-state NMR
All experiments were performed on a Chemagnetics/Varian Infinity 400 MHz solid-state NMR spectrometer operating at resonance frequencies of 400.14 MHz and 161.979 MHz for 1H- and 31P-nuclei, respectively. A built-in temperature control unit was used to maintain the sample's temperature; each sample was allowed to equilibrate at least 30 min before starting the experiment. Unless otherwise noted, experiments were performed at 30°C. The spectra of mechanically aligned samples were obtained using two home-built double resonance probes. One had a four turn square coil (14 mm x 14 mm x 4 mm) constructed from 2-mm wide flat wire with a spacing of 1 mm between turns and the other had a six-turn square coil (14 mm x 14 mm x 2 mm) made from the same material. A typical 31P-90°-pulse length of 3.1 µs was used in both probes. Unless otherwise noted, all samples in the NMR probe were oriented with the lipid bilayer normal parallel to the external magnetic field of the spectrometer, which is defined as the parallel orientation. Some experiments were also performed on samples oriented with the bilayer normal perpendicular to the external magnetic field; this is referred to as the perpendicular orientation. The 31P-chemical shift spectra were obtained using a spin-echo sequence (90°-
-180°-
,
= 100 µs) and a 40 kHz proton-decoupling RF field; the second half of the spin-echo was acquired. A 50-kHz 31P-chemical shift spectral width and a recycle delay of 3 s were used. A typical spectrum required the co-addition of 1001000 transients. The 31P-spectra are referenced relative to 85% H3PO4 on thin glass plates (0 ppm). Data processing was accomplished using the software Spinsight (Chemagnetics/Varian) on a Sun Sparc workstation and IGOR 3.14 (Wavemetrics, Lake Oswego, OR) on a PC.
Differential scanning calorimetry
MSI-78 and DiPoPE were codissolved in a 2:1 CHCl3:CH3OH solution. The solution was dried under a stream of nitrogen, which was followed by drying under high vacuum for several hours. Enough buffer (10 mM Tris-HCl, 100 mM NaCl, 2 mM EDTA, pH = 7.4) was added to each sample to produce a 10 mg/ml lipid solution. The resultant solution was vortexed and then degassed. The fluid lamellar phase (L
) to inverted hexagonal phase (HII) transition temperature of the lipids was measured with a CSC 6100 Nano II Differential Scanning Calorimeter (Calorimetry Sciences, Provo, UT). The data were processed using the software provided by the manufacturer. The heating rate of all experiments was 1°C/min.
| RESULTS |
|---|
|
|
|---|
-to-HII phase transition temperature (TH) of DiPoPE, a standard lipid used for these experiments (Epand and Epand, 2000
|
-to-HII phase transition can also be monitored using 31P-NMR of mechanically aligned samples. POPE bilayers undergo an L
-to-HII phase transition at 72°C. The 31P-chemical shift spectrum shown in Fig. 2 A (solid line) was obtained from pure POPE bilayers at 30°C in the parallel orientation (bilayer normal parallel to the magnetic field); as expected, this sample exhibited a single peak at 28.8 ppm showing the sample is well aligned. The 31P-NMR spectrum of the same sample at 30°C in the perpendicular orientation exhibited a single peak at -14.0 ppm (Fig. 2 B). As illustrated in Fig. 2, lipids in the parallel orientation have their main axis of rotation parallel to the external magnetic field (right side of Fig. 2 A), and in the perpendicular orientation, this rotational axis is perpendicular to the magnetic field (right side of Fig. 2 B). Because the lipids have only a single orientation with respect to the external magnetic field in both sample alignments, only one peak was observed in the 31P-NMR spectra. When the sample was heated to 80°C, which is above the L
-to-HII phase transition temperature, POPE in the HII phase exhibited a single peak at 4.5 ppm in the parallel orientation (Fig. 2 C), but when the sample was rotated by 90° to the perpendicular orientation, the 31P-NMR spectrum of HII phase lipids had a chemical shift span of
20 ppm (Fig. 2 D, solid line). The reason these spectra differ from spectra of L
phase lipids is that the HII phase tubes form between adjacent bilayers and therefore the aligned bilayers result in the formation of HII phase tubes in a plane parallel to the surface of the glass plates as illustrated on the right side of Fig. 2 C. In the parallel orientation, all of these tubes have their tubular axis perpendicular to the external magnetic field and exhibit the same NMR frequency. When the sample is turned 90° to the perpendicular direction, the axes of the tubes are randomly distributed in two dimensions relative to the external magnetic field (shown on the right side in Fig. 2 D), which results in the 31P-spectrum shown in Fig. 2 D. The observed lineshape is indicative of two-dimensional disorder within the mechanically aligned hexagonal phase sample (Fig. 2 D) and can be simulated assuming a circular distribution (Moll and Cross, 1990
|
-to-HII phase transition of POPE, samples containing 1% and 10% peptide concentrations were heated to 75°C, above the L
-to-HII phase transition temperature. Fig. 4 shows the 31P-chemical shift spectra of mechanically aligned POPE bilayers containing 1% MSI-78, acquired at 30°C (Fig. 4 A) and 75°C (Fig. 4 B). The 30°C sample had an intense peak at 27 ppm, but when the temperature was increased to 75°C, the only significant intensity was at 4.7 ppm (Fig. 4 B), which is similar to the 31P-NMR spectra observed from pure POPE bilayers at comparable orientation and temperatures (compare Fig. 4 with Fig. 2, A and C). Based on this, we conclude that the presence of 1% MSI-78 does not significantly inhibit the L
-to-HII phase transition of POPE bilayers. However, this phase transition was prevented by the inclusion of 10% MSI-78 in POPE bilayers (Fig. 4, CD). The 10% peptide sample in POPE at 30°C is shown in Fig. 4 C and the most intense peak was at 25.8 ppm. However at 75°C, the main peak shifted to 24.1 ppm and no peak indicating hexagonal phase formation (45 ppm) was observed (Fig. 4 D). The prevention of the formation of HII is consistent with MSI-78 inducing positive curvature strain in lipid bilayers and inhibiting the formation of inverted phases, in agreement with the DSC data.
|
|
|
| DISCUSSION |
|---|
|
|
|---|
-helical, antimicrobial analog of the magainin family of peptides. The DSC data (Fig. 1) and the variable temperature 31P-NMR data (Fig. 4) show that MSI-78 induces positive curvature strain in lipid bilayers similar to magainin2, a member of the magainin family of antimicrobial peptides (Matsuzaki et al., 1998
At low concentrations (15%), the 31P-spectra of peptide-containing POPC bilayers exhibited unusual lineshapes. These lineshapes reflect the orientational distribution of the lipid headgroups in the sample, but the spectra observed from the samples are not a typical lineshape, i.e, of a lamellar phase, hexagonal phase, isotropic phase, or crystalline powder distribution; some other distribution must be present to generate this lineshape. Because of the structural similarities between MSI-78 and magainin2, a reasonable hypothesis is that MSI-78 forms toroidal pores (Fig. 6 A) similar to magainin2 (Matsuzaki et al., 1998
). To simulate a 31P-spectrum expected from lipids in any distribution, the angular dependence of the observed chemical shift (
obs) and its distribution (or shape factor) must be known. For a rigid powder sample, the former is expressed by
![]() | (1) |
![]() | (2) |
ii (i = 1,2,3) are the principal components of the chemical shielding tensor,
is the angle between
33 and the external magnetic field (B0), and
is the angle between
11 and the projection of B0 onto the
11
22 plane. For lipids in a fluid phase,
![]() | (3) |
![]() | (4) |
|| and 
are the tensor components parallel and perpendicular to the lipids main axis of rotation, respectively. The angle
is the same as above, b is the thickness of the lipid monolayer, and a is the radius of the pore at its smallest diameter as shown in Fig. 6 B. To evaluate this model, we assumed the thickness of the peptide-containing bilayer was the same as a bilayer composed solely of POPC, which is
40 Å (Vogel et al., 2000
|
|
|
![]() | (5) |
6800 Å2 for a toroidal pore with b = 20 Å and a = 10 Å. If we assume that POPC has a cross-sectional area of 65 Å2 (Marsh, 1990
3 lipids, suggesting that
90 lipids participate in the formation of each toroidal pore. Therefore, 90% of the lipids are expected to participate in pore formation at 5% peptide concentration, demonstrating that the assumption of 100% participation is reasonable. Regarding the second assumption, if the lipids were moving rapidly on the NMR timescale, an average peak would be observed between 12 and 20 ppm (depending on pore size). In the above spectra, low-intensity peaks in this range were observed in POPE bilayers containing MSI-78 (Fig. 3) and POPC bilayers containing low concentrations of MSI-78 (most notably Fig. 5 D). The combination of a low-intensity peak and an intense broad component suggests a small percentage of lipids are moving rapidly across the bilayer on the NMR timescale while the majority are in toroidal pore structures that are moving slowly. This variation might be caused by a distribution of pore structures, with some pores stable on the NMR timescale and others not. Additional investigation is required to better understand this phenomenon, but based on the observed relative spectral intensity, the majority of lipids are static on the NMR timescale.
Considering the third assumption, the possibility of a change in the 31P-CSA and/or motional axis of the lipid leading to the observed lineshapes in Fig. 5 cannot be excluded (Thayer and Kohler, 1981
), but we consider it improbable. It seems unlikely that the presence of peptide would significantly alter the 31P-CSA in POPC bilayers without causing similar changes in the CSA of POPE bilayers (compare Fig. 5 with Fig. 3). If headgroup reorientation occurred, the observed 31P-CSA span would have changed (Thayer and Kohler, 1981
) and the span did not change significantly as shown in Fig. 5; only the spectral lineshapes were altered by the presence of peptide. In conclusion, the toroidal model is consistent with the observed lineshapes, but it is not the only possible explanation; another possibility is the peptide inducing a mosaic spread in the aligned bilayer sample. This possibility will be discussed after the high concentration peptide samples are considered.
When the concentration of MSI-78 is 10% in POPC bilayers (Fig. 5 E), a peak at 5.3 ppm is present that is similar to the 4.5-ppm peak originating from HII phase lipids observed in samples of pure POPE at 80°C (Fig. 2 C). However, the DSC data (Fig. 1) and 31P-NMR (Fig. 4) demonstrate that MSI-78 induces positive curvature strain, which is inconsistent with the peptide-induced formation of HII. But, lipids in an HI phase would produce an identical peak, and the formation of HI would be consistent with MSI-78 inducing positive curvature strain. Instead of a different lipid phase, the 5.3-ppm peak could also represent a peptide-induced conformational/orientational change in the lipids (Noggle et al., 1982
). In this hypothesis, the lipids remain in an L
bilayer, but the orientation of the lipid headgroup has changed. The nature of the L
phase dictates that a single peak is observed in both the parallel and perpendicular directions as shown in Fig. 2, A and B, respectively. However, the 31P-chemical shift spectrum of 10% MSI-78 in POPC in the perpendicular orientation rules out this possibility. Fig. 8 shows the 31P-chemical shift spectrum of 10% MSI-78 peptide in POPC sample in the parallel (Fig. 8 A, solid line) and perpendicular (Fig. 8 B, solid line) orientations. A single peak was not observed in the perpendicular orientation, eliminating the possibility that the 5.3-ppm peak was caused by the lipids uniformly adopting a different orientation. In fact, Fig. 8 B has a lineshape similar to the spectrum obtained from HII phase lipids in the perpendicular sample orientation (Fig. 2 D, solid line). However, Fig. 8 B has significantly more intensity near -15 ppm because the 10% MSI-78 in POPC sample contains multiple components, most likely a combination of lipids in toroidal pores and HI phase. To simulate the spectra shown in Fig. 8, the relative percentages of the components must be determined. The two phases are easily distinguished in Fig. 8 A because the components exhibit excellent resolution in the parallel orientation. Fig. 8 A can be simulated assuming 73% of the lipids are in toroidal pores and the other 27% are in an HI phase (Fig. 8 A, dashed line). Using the same percentages of both phases, the perpendicular orientation was also fit (Fig. 8 B, dashed line). These simulations demonstrate that the 31P-spectra of high concentrations MSI-78 in POPC induce changes in lipid bilayers consistent with the presence of toroidal pores and HI phase lipids, but this is not an exclusive explanation. As was mentioned previously, a large mosaic spread could cause the observation of lineshape ascribed to toroidal pores.
|
phase and the HI phase at intermediate concentrations. Consider the scheme shown in Fig. 9: without any peptide, the lipids form aligned bilayers (Fig. 9 A). With the addition of a low concentration of MSI-78, the 31P-NMR spectra suggest that the lipids either induce a mosaic spread (Fig. 9 B) or the formation of toroidal pores (Fig. 9 C) in the sample. At high peptide concentrations, the peptide induces the formation of an aligned HI phase (Fig. 9 D). It seems unlikely the peptide would induce a large mosaic spread at low concentrations and an aligned hexagonal phase at high concentrations; this route is shown in the top scheme (Fig. 9 A
9 B
9 D). The bottom scheme (Fig. 9 A
9 C
9 D), which includes toroidal pores as an intermediate structure, is similar to a mechanism proposed for L
-to-HII phase transitions (Siegel, 1999The structure of the proposed peptide-induced HI phase is not known, but it may be similar to the illustration shown in Fig. 10 A. In this model, the peptides are end-to-end with a peptide-lipid structure similar to that of a toroidal pore (Fig. 6 A). In the absence of information about the peptide's orientation, it is possible that the peptide intercalates between lipid headgroups, tilting them away from the peptide with the lipid's acyl chains tilt inward, filling the space beneath the peptide as shown in Fig. 10 B. In this case, the lipids along the sides of the peptide would be tilted significantly more than the lipids at the end of the helix. Additional investigation is currently underway to better characterize the nature of the peptide-induced HI phase.
|
Before concluding, the biological relevance of using high peptide concentrations and zwitterionic membranes to study antimicrobial peptides needs to be discussed. High peptide concentrations are not required for antimicrobial activity; in fact, only micromolar concentrations of MSI-78 or magainin2 are necessary to inhibit bacterial growth (Maloy and Kari, 1995
), although total cell lysis is not observed until magainin2 reaches concentrations of 10% (Matsuzaki et al., 1997
). But, minimum inhibitory concentrations measure the concentration of the peptide in bulk solution, not near the surface of the bacterial membrane, or more importantly, the ratio of peptide to lipid during pore formation. This latter event is poorly understood. Peptide association or aggregation and peptide-lipid complex formation is required to form the pore (Matsuzaki, 1998
; Oren and Shai, 1998
; Andreu and Rivas, 1998
). Currently, little information is available about the peptide-to-lipid ratio in the pre-pore complex or during pore formation, but concentration of peptide is expected to be higher than micromolar. In an effort to gain insight into these transient pore-forming species, high concentrations of peptide were used to mimic the high concentrations of peptide likely to be present in the pre-pore and pore complexes.
In this work, the effect of MSI-78 on bilayers composed of zwitterionic lipids was studied, not the peptide's effect on bilayers containing both zwitterionic and anionic lipids which more closely mimic bacterial membranes. Although it has been shown that anionic lipids attract cationic peptides to the lipid-water interface and are an essential selection filter for antimicrobial peptides, anionic lipids are not essential for the binding of cationic peptides such as magainin2 and PGLa to lipid bilayers (Dathe and Wieprecht, 1999
; Wieprecht et al., 2000
; Bechinger et al., 1993
). In fact, Wieprecht and co-workers demonstrated that if the magainins are assumed to be initially present in the lipid-water interface, then "magainins would bind distinctly better to neutral than to charged membranes" (Wieprecht et al., 1999
). In the mechanically aligned bilayers used throughout this work, bulk water is absent from the samples, thus eliminating the need for long-range electrostatic interactions to induce peptide aggregation near the bilayer surface; in other words, the peptides are always at the lipid-water interface and the presence of anionic lipids is not required for peptide interaction with the bilayer. The changes reported in this manuscript verify that MSI-78 interacts with lipid bilayers in the absence of anionic lipids.
| CONCLUSION |
|---|
|
|
|---|
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
This research was supported by research funds from the National Science Foundation (CAREER development award to A.R.). K.J.H. was supported by the National Institutes of Health-Michigan Molecular Biophysics Training Program (GM08270).
| FOOTNOTES |
|---|
, fluid lamellar phase; NMR, nuclear magnetic resonance spectroscopy; POPC, 1-palmitoyl-2-oleoyl-phosphatidylcholine; POPE, 1-palmitoyl-2-oleoyl-phosphatidylethanolamine. Submitted on April 4, 2002; accepted for publication December 4, 2002.
| REFERENCES |
|---|
|
|
|---|
Bechinger, B., M. Zasloff, and S. J. Opella. 1993. Structure and orientation of the antibiotic peptide magainin in membranes by solid-state nuclear magnetic resonance spectroscopy. Protein Sci. 2:20772084.[Abstract]
Dathe, M., and T. Wieprecht. 1999. Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. Biochim. Biophys. Acta Biomembr. 1462:7187.[Medline]
Epand, R. M., and R. F. Epand. 2000. Modulation of membrane curvature by peptides. Biopolymers. 55:358363.[Medline]
Fenske, D. B., and H. C. Jarrell. 1991. 31P-two-dimensional solid-state exchange NMRapplication to model membrane and biological systems. Biophys. J. 59:5569.
Funari, S. S., C. DiVitta, and G. Rapp. 1997. X-ray diffraction and NMR studies on mixtures of non-ionic surfactant (C12EO2) and phospholipids (POPC). Acta Phys. Pol. A. 91:953960.
Garcia-Olmedo, F., A. Molina, J. M. Alamillo, and P. Rodriguez-Palenzuela. 1998. Plant defense peptides. Biopolymers. 47:479491.[Medline]
Gasset, M., J. A. Killian, H. Tournois, and B. de Kruijff. 1988. Influence of cholesterol on gramicidin-induced HII phase formation in phosphatidylcholine model membranes. Biochim. Biophys. Acta. 939:7988.[Medline]
Hallock, K. J., K. Henzler Wildman, D. K. Lee, and A. Ramamoorthy. 2002. An innovative procedure using a sublimable solid to align lipid bilayers for solid-state NMR studies. Biophys. J. 82:24992503.
Janes, N. 1996. Curvature stress and polymorphism in membranes. Chem. Phys. Lipids. 81:133150.
Keller, S. L., S. M. Gruner, and K. Gawrisch. 1996. Small concentrations of alamethicin induce a cubic phase in bulk phosphatidylethanolamine mixtures. Biochim. Biophys. Acta Biomembr. 1278:241246.[Medline]
Killian, J. A., and B. de Kruijff. 1985. Importance of hydration for gramicidin-induced hexagonal-HII phase formation in dioleoylphosphatidylcholine model membranes. Biochemistry. 24:78907898.[Medline]
Liu, F., R. Lewis, R. S. Hodges, and R. N. McElhaney. 2001. A differential scanning calorimetric and P-31 NMR spectroscopic study of the effect of transmembrane alpha-helical peptides on the lamellar-reversed hexagonal phase transition of phosphatidylethanolamine model membranes. Biochemistry. 40:760768.[Medline]
Maloy, W. L., and U. P. Kari. 1995. Structure-activity studies on magainins and other host defense peptides. Biopolymers. 37:105122.[Medline]
Marsh, D. 1990. CRC Handbook of Lipid Bilayers. CRC Press, Boca Raton, FL. pp. 387.
Matsuzaki, K. 1998. Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim. Biophys. Acta. 1376:391400.[Medline]
Matsuzaki, K., K. Sugishita, M. Harada, N. Fujii, and K. Miyajima. 1997. Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria. Biochim. Biophys. Acta. 1327:119130.[Medline]
Matsuzaki, K., K. Sugishita, N. Ishibe, M. Ueha, S. Nakata, K. Miyajima, and R. M. Epand. 1998. Relationship of membrane curvature to the formation of pores by magainin 2. Biochemistry. 37:1185611863.[Medline]
Moll, F. D., and T. A. Cross. 1990. Optimizing and characterizing alignment of oriented lipid bilayers containing gramicidin D. Biophys. J. 57:351362.
Noggle, J. H., J. F. Marecek, S. B. Mandal, R. Vanvenetie, J. Rogers, M. K. Jain, and F. Ramirez. 1982. Bilayers of phosphatidyldiacylglycerol and phosphatidylcholesterol give 31P-NMR spectra characteristic for hexagonal and isotropic phases. Biochim. Biophys. Acta. 691:240248.
Oren, Z., and Y. Shai. 1998. Mode of action of linear amphipathic alpha-helical antimicrobial peptides. Biopolymers. 47:451463.[Medline]
Siegel, D. P. 1999. The modified stalk mechanism of lamellar/inverted phase transitions and its implications for membrane fusion. Biophys. J. 76:291313.
Stewart, J. 1991. Calculus. Brooks/Cole Publishing Company, Pacific Grove, CA.
Thayer, A. M., and S. J. Kohler. 1981. Phosphorus-31 nuclear magnetic resonance spectra characteristic of hexagonal and isotropic phospholipid phases generated from phosphatidylethanolamine in the bilayer phase. Biochemistry. 20:68316834.[Medline]
Vogel, M., C. Munster, W. Fenzl, and T. Salditt. 2000. Thermal unbinding of highly oriented phospholipid membranes. Phys. Rev. Lett. 84:390393.[Medline]
Washburn, E. W., C. J. West, and C. Hull. 1926. International Critical Tables of Numerical Data, Physics, Chemistry, and Technology. Published for the National Research Council by McGraw-Hill, New York.
Wieprecht, T., O. Apostolov, M. Beyermann, and J. Seelig. 2000. Membrane binding and pore formation of the antibacterial peptide PGLa: thermodynamic and mechanistic aspects. Biochemistry. 39:442452.[Medline]
Wieprecht, T., M. Beyermann, and J. Seelig. 1999. Binding of antibacterial magainin peptides to electrically neutral membranes: thermodynamics and structure. Biochemistry. 38:1037710387.[Medline]
Wieprecht, T., M. Dathe, R. M. Epand, M. Beyermann, E. Krause, W. L. Maloy, D. L. MacDonald, and M. Bienert. 1997. Influence of the angle subtended by the positively charged helix face on the membrane activity of amphipathic, antibacterial peptides. Biochemistry. 36:1286912880.[Medline]
Zasloff, M. 1987. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. USA. 84:54495453.
This article has been cited by other articles:
![]() |
P. Wessman, A. A. Stromstedt, M. Malmsten, and K. Edwards Melittin-Lipid Bilayer Interactions and the Role of Cholesterol Biophys. J., November 1, 2008; 95(9): 4324 - 4336. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Abu-Baker, X. Qi, and G. A. Lorigan Investigating the Interaction of Saposin C with POPS and POPC Phospholipids: A Solid-State NMR Spectroscopic Study Biophys. J., November 15, 2007; 93(10): 3480 - 3490. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Shental-Bechor, T. Haliloglu, and N. Ben-Tal Interactions of Cationic-Hydrophobic Peptides with Lipid Bilayers: A Monte Carlo Simulation Method Biophys. J., September 15, 2007; 93(6): 1858 - 1871. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pistolesi, R. Pogni, and J. B. Feix Membrane Insertion and Bilayer Perturbation by Antimicrobial Peptide CM15 Biophys. J., September 1, 2007; 93(5): 1651 - 1660. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-L. Pan, J. T.-J. Cheng, J. Hale, J. Pan, R. E. W. Hancock, and S. K. Straus Characterization of the Structure and Membrane Interaction of the Antimicrobial Peptides Aurein 2.2 and 2.3 from Australian Southern Bell Frogs Biophys. J., April 15, 2007; 92(8): 2854 - 2864. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. A. Domanov and P. K. J. Kinnunen Antimicrobial Peptides Temporins B and L Induce Formation of Tubular Lipid Protrusions from Supported Phospholipid Bilayers Biophys. J., December 15, 2006; 91(12): 4427 - 4439. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Tremouilhac, E. Strandberg, P. Wadhwani, and A. S. Ulrich Synergistic Transmembrane Alignment of the Antimicrobial Heterodimer PGLa/Magainin J. Biol. Chem., October 27, 2006; 281(43): 32089 - 32094. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ramamoorthy, S. Thennarasu, D.-K. Lee, A. Tan, and L. Maloy Solid-State NMR Investigation of the Membrane-Disrupting Mechanism of Antimicrobial Peptides MSI-78 and MSI-594 Derived from Magainin 2 and Melittin Biophys. J., July 1, 2006; 91(1): 206 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ouellet, G. Bernard, N. Voyer, and M. Auger Insights on the Interactions of Synthetic Amphipathic Peptides with Model Membranes as Revealed by 31P and 2H Solid-State NMR and Infrared Spectroscopies Biophys. J., June 1, 2006; 90(11): 4071 - 4084. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mecke, D.-K. Lee, A. Ramamoorthy, B. G. Orr, and M. M. Banaszak Holl Membrane Thinning Due to Antimicrobial Peptide Binding: An Atomic Force Microscopy Study of MSI-78 in Lipid Bilayers Biophys. J., December 1, 2005; 89(6): 4043 - 4050. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nomura, G. Ferrat, T. Nakajima, H. Darbon, T. Iwashita, and G. Corzo Induction of Morphological Changes in Model Lipid Membranes and the Mechanism of Membrane Disruption by a Large Scorpion-Derived Pore-Forming Peptide Biophys. J., December 1, 2005; 89(6): 4067 - 4080. [Abstract] [Full Text] [PDF] |
||||